 Steven Coultrap
Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 28 | 2025 | 188 | 5.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 21 | 2025 | 219 | 1.760 |
Why?
| | Long-Term Potentiation | 16 | 2025 | 198 | 1.550 |
Why?
| | Hippocampus | 24 | 2025 | 895 | 1.050 |
Why?
| | Calcium | 7 | 2023 | 1199 | 0.980 |
Why?
| | Phosphorylation | 27 | 2025 | 1759 | 0.890 |
Why?
| | Long-Term Synaptic Depression | 5 | 2017 | 56 | 0.840 |
Why?
| | Neurons | 14 | 2025 | 1590 | 0.690 |
Why?
| | Synapses | 7 | 2023 | 427 | 0.640 |
Why?
| | Nitric Oxide | 2 | 2014 | 915 | 0.610 |
Why?
| | Calmodulin | 5 | 2014 | 76 | 0.610 |
Why?
| | Memory | 4 | 2017 | 248 | 0.540 |
Why?
| | Second Messenger Systems | 1 | 2014 | 31 | 0.440 |
Why?
| | Neuroprotective Agents | 4 | 2025 | 131 | 0.410 |
Why?
| | HEK293 Cells | 7 | 2025 | 730 | 0.390 |
Why?
| | Receptors, Serotonin | 3 | 2002 | 34 | 0.380 |
Why?
| | Rats | 25 | 2025 | 5647 | 0.380 |
Why?
| | Protein Kinase Inhibitors | 5 | 2018 | 916 | 0.350 |
Why?
| | Synaptic Transmission | 2 | 2012 | 289 | 0.340 |
Why?
| | Amino Acid Sequence | 6 | 2017 | 2139 | 0.340 |
Why?
| | Drug Design | 1 | 2011 | 167 | 0.340 |
Why?
| | Glutamic Acid | 6 | 2023 | 246 | 0.330 |
Why?
| | Protein Kinase C | 3 | 2002 | 261 | 0.320 |
Why?
| | Amyloid beta-Peptides | 2 | 2025 | 220 | 0.320 |
Why?
| | Molecular Sequence Data | 6 | 2014 | 2900 | 0.310 |
Why?
| | Death-Associated Protein Kinases | 2 | 2020 | 11 | 0.300 |
Why?
| | Peptides | 2 | 2011 | 985 | 0.290 |
Why?
| | Receptors, AMPA | 5 | 2018 | 141 | 0.290 |
Why?
| | Animals | 38 | 2025 | 36940 | 0.290 |
Why?
| | Brain Ischemia | 1 | 2011 | 338 | 0.280 |
Why?
| | Substrate Specificity | 3 | 2014 | 372 | 0.260 |
Why?
| | Rats, Sprague-Dawley | 15 | 2020 | 2486 | 0.250 |
Why?
| | Protein Binding | 8 | 2025 | 2224 | 0.230 |
Why?
| | Cyclopentanes | 1 | 2025 | 19 | 0.230 |
Why?
| | Heart Arrest | 2 | 2020 | 339 | 0.220 |
Why?
| | Brain | 2 | 2018 | 2668 | 0.220 |
Why?
| | Alternative Splicing | 1 | 2005 | 229 | 0.200 |
Why?
| | Isoenzymes | 2 | 2014 | 304 | 0.200 |
Why?
| | Holoenzymes | 2 | 2021 | 24 | 0.190 |
Why?
| | Ethanol | 4 | 2011 | 608 | 0.190 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 150 | 0.190 |
Why?
| | In Vitro Techniques | 10 | 2010 | 1092 | 0.190 |
Why?
| | Gene Expression Regulation | 4 | 2010 | 2607 | 0.180 |
Why?
| | Cell Death | 4 | 2020 | 374 | 0.180 |
Why?
| | Enzyme Inhibitors | 4 | 2005 | 840 | 0.180 |
Why?
| | Neuroprotection | 2 | 2020 | 42 | 0.170 |
Why?
| | Models, Molecular | 3 | 2017 | 1570 | 0.160 |
Why?
| | Neuronal Plasticity | 5 | 2025 | 290 | 0.160 |
Why?
| | Maleimides | 1 | 1999 | 23 | 0.160 |
Why?
| | Mice | 12 | 2024 | 17787 | 0.160 |
Why?
| | Serotonin Antagonists | 1 | 1999 | 32 | 0.160 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2011 | 182 | 0.150 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2002 | 434 | 0.150 |
Why?
| | Ischemia | 2 | 2020 | 409 | 0.140 |
Why?
| | Lipoylation | 1 | 2017 | 17 | 0.140 |
Why?
| | Protein Conformation | 3 | 2021 | 934 | 0.140 |
Why?
| | Peptide Fragments | 3 | 2018 | 706 | 0.140 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2018 | 283 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 2 | 2017 | 465 | 0.140 |
Why?
| | Synaptic Membranes | 2 | 2008 | 18 | 0.140 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 72 | 0.130 |
Why?
| | Protein Tyrosine Phosphatases | 4 | 2012 | 172 | 0.130 |
Why?
| | Mutation | 4 | 2020 | 3958 | 0.130 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2014 | 39 | 0.120 |
Why?
| | Indoles | 1 | 1999 | 412 | 0.120 |
Why?
| | Spine | 1 | 2017 | 173 | 0.120 |
Why?
| | Excitatory Postsynaptic Potentials | 3 | 2014 | 124 | 0.120 |
Why?
| | Central Nervous System Depressants | 2 | 2010 | 85 | 0.120 |
Why?
| | Adenosine Triphosphate | 3 | 2013 | 491 | 0.110 |
Why?
| | Cell Line | 3 | 2011 | 2847 | 0.110 |
Why?
| | Phosphoserine | 1 | 2014 | 34 | 0.110 |
Why?
| | Neural Inhibition | 2 | 2012 | 169 | 0.110 |
Why?
| | Humans | 18 | 2025 | 137585 | 0.110 |
Why?
| | Tyrosine | 2 | 2005 | 222 | 0.100 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 283 | 0.100 |
Why?
| | Subcellular Fractions | 3 | 2007 | 82 | 0.100 |
Why?
| | Protein Subunits | 3 | 2013 | 239 | 0.100 |
Why?
| | Protein Transport | 5 | 2018 | 445 | 0.100 |
Why?
| | Receptors, Serotonin, 5-HT3 | 3 | 2002 | 15 | 0.100 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 861 | 0.090 |
Why?
| | Blotting, Western | 5 | 2007 | 1226 | 0.090 |
Why?
| | Enzyme Activation | 4 | 2017 | 810 | 0.090 |
Why?
| | Xenopus laevis | 3 | 2002 | 106 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 145 | 0.090 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 3 | 0.090 |
Why?
| | Autophagy | 1 | 2014 | 284 | 0.090 |
Why?
| | Solutions | 1 | 2011 | 168 | 0.090 |
Why?
| | Serine | 1 | 2011 | 141 | 0.090 |
Why?
| | Pyramidal Cells | 2 | 2010 | 74 | 0.090 |
Why?
| | Mutagenesis | 1 | 2011 | 179 | 0.090 |
Why?
| | Alanine | 1 | 2011 | 152 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1060 | 0.090 |
Why?
| | Nucleotides | 1 | 2011 | 125 | 0.090 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.080 |
Why?
| | Mice, Inbred C57BL | 4 | 2024 | 5757 | 0.080 |
Why?
| | Kinetics | 2 | 2011 | 1670 | 0.080 |
Why?
| | Signal Transduction | 3 | 2014 | 5079 | 0.080 |
Why?
| | Oocytes | 2 | 2002 | 181 | 0.080 |
Why?
| | Corpus Striatum | 1 | 2011 | 167 | 0.080 |
Why?
| | Transfection | 2 | 2017 | 945 | 0.080 |
Why?
| | Green Fluorescent Proteins | 2 | 2025 | 390 | 0.080 |
Why?
| | Patch-Clamp Techniques | 3 | 2010 | 286 | 0.080 |
Why?
| | Dendritic Spines | 2 | 2020 | 65 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 553 | 0.070 |
Why?
| | Staurosporine | 2 | 2013 | 20 | 0.070 |
Why?
| | Male | 16 | 2024 | 67762 | 0.070 |
Why?
| | Benzylamines | 3 | 2010 | 41 | 0.060 |
Why?
| | Protein Domains | 2 | 2018 | 289 | 0.060 |
Why?
| | Septum of Brain | 1 | 2005 | 4 | 0.060 |
Why?
| | Cholinergic Fibers | 1 | 2005 | 18 | 0.060 |
Why?
| | Nerve Growth Factor | 1 | 2005 | 30 | 0.060 |
Why?
| | Synapsins | 1 | 2005 | 14 | 0.060 |
Why?
| | Actinin | 1 | 2005 | 13 | 0.060 |
Why?
| | Nerve Net | 1 | 2007 | 256 | 0.060 |
Why?
| | Animals, Newborn | 3 | 2014 | 844 | 0.050 |
Why?
| | Thiazolidinediones | 1 | 2004 | 137 | 0.050 |
Why?
| | Seizures | 1 | 2007 | 426 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2018 | 4193 | 0.050 |
Why?
| | Excitatory Amino Acid Antagonists | 3 | 2010 | 100 | 0.050 |
Why?
| | Receptors, Glutamate | 1 | 2002 | 25 | 0.050 |
Why?
| | RNA, Complementary | 1 | 2002 | 3 | 0.050 |
Why?
| | Optogenetics | 1 | 2023 | 108 | 0.050 |
Why?
| | Antigens, Surface | 1 | 2002 | 154 | 0.050 |
Why?
| | Single Molecule Imaging | 1 | 2021 | 37 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2002 | 272 | 0.050 |
Why?
| | Fear | 1 | 2004 | 338 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 596 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2002 | 375 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2002 | 307 | 0.040 |
Why?
| | Neurotoxins | 1 | 2020 | 29 | 0.040 |
Why?
| | Phenanthridines | 1 | 1999 | 7 | 0.040 |
Why?
| | Benzophenanthridines | 1 | 1999 | 10 | 0.040 |
Why?
| | 2-Amino-5-phosphonovalerate | 2 | 2010 | 10 | 0.040 |
Why?
| | Electrophysiology | 3 | 2007 | 217 | 0.040 |
Why?
| | Binding Sites | 2 | 2014 | 1303 | 0.040 |
Why?
| | Alkaloids | 1 | 1999 | 30 | 0.040 |
Why?
| | Cell Membrane | 2 | 2002 | 738 | 0.040 |
Why?
| | Learning | 1 | 2023 | 409 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1999 | 202 | 0.040 |
Why?
| | Naphthalenes | 1 | 1999 | 60 | 0.040 |
Why?
| | Cross-Linking Reagents | 3 | 2007 | 217 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1353 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2018 | 66 | 0.040 |
Why?
| | Electric Stimulation | 2 | 2010 | 264 | 0.040 |
Why?
| | Base Sequence | 1 | 2002 | 2181 | 0.040 |
Why?
| | Resuscitation | 1 | 2020 | 251 | 0.030 |
Why?
| | Exons | 1 | 2018 | 355 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2017 | 443 | 0.030 |
Why?
| | Disks Large Homolog 4 Protein | 2 | 2007 | 18 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 404 | 0.030 |
Why?
| | Sulfonamides | 2 | 2010 | 513 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2017 | 192 | 0.030 |
Why?
| | Female | 6 | 2021 | 73304 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2017 | 177 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 2005 | 265 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 10 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 2057 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1316 | 0.030 |
Why?
| | Pepstatins | 1 | 2014 | 4 | 0.030 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 15 | 0.030 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 64 | 0.030 |
Why?
| | Aging | 1 | 2004 | 1864 | 0.030 |
Why?
| | Muramidase | 1 | 2014 | 78 | 0.030 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 28 | 0.030 |
Why?
| | Adenosine Diphosphate | 1 | 2013 | 79 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 269 | 0.030 |
Why?
| | Leucine | 1 | 2014 | 111 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2007 | 455 | 0.030 |
Why?
| | Point Mutation | 1 | 2014 | 235 | 0.030 |
Why?
| | Protease Inhibitors | 1 | 2014 | 107 | 0.030 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 143 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 431 | 0.020 |
Why?
| | Memantine | 1 | 2012 | 14 | 0.020 |
Why?
| | RNA | 1 | 1999 | 921 | 0.020 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 196 | 0.020 |
Why?
| | N-Methylaspartate | 1 | 2012 | 40 | 0.020 |
Why?
| | DNA | 1 | 1999 | 1459 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 469 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2014 | 341 | 0.020 |
Why?
| | Alzheimer Disease | 1 | 2018 | 560 | 0.020 |
Why?
| | Immunohistochemistry | 2 | 2007 | 1738 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 622 | 0.020 |
Why?
| | Caspase 3 | 1 | 2012 | 246 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 418 | 0.020 |
Why?
| | Bicuculline | 1 | 2010 | 23 | 0.020 |
Why?
| | Phosphinic Acids | 1 | 2010 | 9 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2010 | 19 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2012 | 142 | 0.020 |
Why?
| | Action Potentials | 1 | 2014 | 493 | 0.020 |
Why?
| | Pregnancy | 2 | 2018 | 6763 | 0.020 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 17 | 0.020 |
Why?
| | Gene Products, tat | 1 | 2010 | 23 | 0.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 21 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2833 | 0.020 |
Why?
| | Membrane Proteins | 2 | 2007 | 1164 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2010 | 307 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2010 | 103 | 0.020 |
Why?
| | Microdissection | 1 | 2008 | 15 | 0.020 |
Why?
| | Propionates | 1 | 2007 | 39 | 0.020 |
Why?
| | Mossy Fibers, Hippocampal | 1 | 2007 | 11 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2010 | 665 | 0.020 |
Why?
| | Kainic Acid | 1 | 2007 | 35 | 0.020 |
Why?
| | Threonine | 1 | 2007 | 47 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2007 | 63 | 0.020 |
Why?
| | Maze Learning | 1 | 2007 | 103 | 0.020 |
Why?
| | Behavior, Animal | 1 | 2010 | 501 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2010 | 433 | 0.020 |
Why?
| | Calnexin | 1 | 2005 | 3 | 0.020 |
Why?
| | Dendrites | 1 | 2007 | 105 | 0.020 |
Why?
| | Phenanthrolines | 1 | 2005 | 7 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2010 | 771 | 0.020 |
Why?
| | Receptor, trkA | 1 | 2005 | 18 | 0.020 |
Why?
| | Mental Recall | 1 | 2007 | 202 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 155 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2005 | 156 | 0.010 |
Why?
| | Phenols | 1 | 2005 | 99 | 0.010 |
Why?
| | Feeding Behavior | 1 | 2010 | 654 | 0.010 |
Why?
| | Organometallic Compounds | 1 | 2005 | 111 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2003 | 100 | 0.010 |
Why?
| | Cell Fractionation | 1 | 2002 | 56 | 0.010 |
Why?
| | Chymotrypsin | 1 | 2002 | 22 | 0.010 |
Why?
| | Cerebrospinal Fluid | 1 | 2002 | 92 | 0.010 |
Why?
| | Peptide Hydrolases | 1 | 2002 | 111 | 0.010 |
Why?
| | Stroke | 1 | 2010 | 1120 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2002 | 92 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2005 | 752 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1783 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6828 | 0.010 |
Why?
| | Algorithms | 1 | 2007 | 1704 | 0.010 |
Why?
| | Age Factors | 1 | 2005 | 3295 | 0.010 |
Why?
|
|
Coultrap's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|